- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02668705
Agent-Enhanced Document Explanation
Research Ethics and Safety Promoted by Embodied Conversational Technology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The main study in this protocol is a 3 arm (HUMAN vs. ECA vs. ECA + HUMAN), randomized, between-subjects experimental design.
There is one sub-study, the Images study, also included in this protocol. Subjects who are eligible for the main study can choose if they would like to participate in this sub-study. This is a within-subjects design, where subjects will be randomized to different conditions within the system.
One additional sub-study, called Stance, also a within-subjects design, where subjects will be randomized to different conditions within the system, was also included in the original protocol,but has since been closed to enrollment. Data collection for this sub-study was the same as for the current sub study (Images), and the main study (Consent Advocate).
Eligible subjects will be given the option to participate in the sub-study in addition to the main study. Subjects may opt out of this sub-study, but not the main study (as in, a subject cannot do the sub-study and NOT do the main study, unless there is some legitimate reason to stop after the sub-study). Due to the nature of the content, the order of the studies must be:
Images (sub) Consent Advocate (main) In these studies, baseline data is collected by the RA verbally administering the instruments to the subjects. Then, the subject will sit in front of a touch-screen monitor to interact with the character on the screen. A member of the research team will be available at all times to assist with any technical issues, or if the subject needs to take a break. Once the on-screen interaction(s) are complete, the RA will administer any post-system data collection instruments.
Due to the amount of time required for data collection and completion of study protocol (each study takes approximately 60-120 minutes), the subject can choose to complete the 2 studies in 1 or 2 study visits, depending on study subject and staff scheduling needs.
Main Study: Consent Advocate In this study, the participant will be randomized to one of three arms: 1) a sham research informed consent form will be explained by a research assistant; 2) a sham research informed consent form will be explained by an ECA, or 3) a sham research informed consent form will be explained by an ECA and then questions will be answered by a research assistant.
Baseline Data Collection:
- Sociodemographics
- Need for Cognition
- Patient Activation
- Trust in Medical System
- REALM
Post Data Collection:
- BICEP (primary outcome measure)
- Trust in Agent
- Instructor Evaluation Permission to audiotape the interaction will be obtained prior to conducting this portion of the sub-study. The audio recording will be used to analyze what questions the participant asks. If assigned to the ECA and RA condition, the audio recording will be used by the research assistant prior to conducting the live consent process. A knowledge test will be conducted after the consent process to ascertain what was understood.
This study should take approximately 60 minutes to complete.
Sub-study:
1. Images. The ECA will explain a consent form but will use images to represent potential risk as opposed to descriptive language only. Understanding will be measured by a knowledge questionnaire. (n=50)
Baseline Data Collection:
Sociodemographics Need for Cognition
Post Data Collection:
Instructor Evaluation Informed Consent Scales Knowledge (of sham consent form) This study should take approximately 60-90 minutes to complete. If a subject participates in the sub-study that requires the same data collection forms (i.e. sociodemographics, need for cognition, etc), these forms will only be completed once for each subject, not for each study they participate in.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- understand spoken and written English (assessed by verbally asking candidates if they "understand spoken and written English")
- Must be an established patient in the Boston Medical Center clinics.
Exclusion Criteria:
- An issue determined by the patient's physician that would make this study inappropriate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Human RA
A sham research informed consent form will be explained by a research assistant
|
|
Experimental: ECA
A sham research informed consent form will be explained by an ECA (embodied conversational agent as presented on a touch screen computer)
|
A computer generated character that can administer informed consent to a potential research subject.
|
Experimental: ECA + Human RA
A sham research informed consent form will be explained by an ECA and then questions will be answered by a research assistant
|
A computer generated character that can administer informed consent to a potential research subject.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the quality of the informed consent process
Time Frame: immediately following the study interview
|
as determined by verbally administering the Brief Informed Consent Evaluation Protocol (BICEP) instrument.
|
immediately following the study interview
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
knowledge of the mock study that was described during study visit
Time Frame: immediately following the study interview
|
determined by knowledge assessment test
|
immediately following the study interview
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CA158219-CA
- 5R01CA158219-05 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Competency
-
Eskisehir Osmangazi UniversityEnrolling by invitationCultural CompetencyTurkey
-
University of Massachusetts, WorcesterBrown University; National Institute on Deafness and Other Communication Disorders...Completed
-
University of OuluThe Finnish Association of Nursing Research; Finnish Nurses AssociationCompletedMentoring | Cultural CompetencyFinland
-
Alvaro Castellanos OrtegaEuropean Society of Intensive Care Medicine; Generalitat ValencianaUnknownCompetency-Based EducationSpain
-
University of Colorado, DenverJohns Hopkins University; Mayo Clinic; University of Pennsylvania; Washington University... and other collaboratorsCompletedCompetency Based Education
-
University of Colorado, DenverHarvard Medical School (HMS and HSDM); Johns Hopkins University; Mayo Clinic; Fox... and other collaboratorsCompletedCompetency-Based Education
-
Yale UniversityAgency for Healthcare Research and Quality (AHRQ)CompletedProcedural Skill CompetencyUnited States
-
Universiti Putra MalaysiaPublic Service Department MalaysiaCompletedCompetence | Competency-Based EducationMalaysia
-
Boehringer IngelheimCompletedMental Fatigue | Mental CompetencyUnited Kingdom
-
NYU Langone HealthNational Library of Medicine (NLM)Completed
Clinical Trials on Embodied Conversational Agent
-
Boston Medical CenterNational Cancer Institute (NCI); Northeastern UniversityCompleted
-
Boston Medical CenterBoston University; National Institute of Nursing Research (NINR); Northeastern...CompletedPalliative CareUnited States
-
Tufts Medical CenterBoston Medical CenterNot yet recruiting
-
Abramson Cancer Center at Penn MedicinePfizer; Lung Cancer Research FoundationActive, not recruitingLung Cancer | Medication Adherence | Symptoms and SignsUnited States
-
University of KlagenfurtMeta Platforms, Inc.Completed
-
Tallaght University HospitalRoyal College of Surgeons, IrelandRecruitingGastro-Intestinal DisorderIreland
-
Nanyang Technological UniversityTan Tock Seng Hospital; Ministry of Health, SingaporeRecruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Diabetes Type 2Singapore
-
Nanyang Technological UniversityTan Tock Seng Hospital; Ministry of Health, SingaporeCompletedDiabetes Mellitus, Type 2 | Diabetic Foot | Diabetic Foot Infection | Ulcer Foot | Diabetes Mellitus Foot Ulcer | Ulcer, LegSingapore
-
Virginia Commonwealth UniversityCompleted
-
University of NebraskaRecruitingLoneliness | Pain, ChronicUnited States